• 121904+ Medical Conferences
  • 247 Specialties
  • 30586 Organizers
  • 142756 Speakers
  • 154 Countries
  • 4268 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Roy Baynes
Roy Baynes

Roy Baynes

    MBBCh, MMed, FCP, MD, PhD
Vice President, Head | Rahway, New Jersey    United States of America
Oncology, Research And Development,...More
Spoken at 21 events
Speaking at 2 events

Biography :

Roy Baynes, MD, PhD, is Senior Vice President Global Clinical Development at Merck Research Laboratories in Rahway, New Jersey. He was previously Senior Vice President of Oncology, Inflammation and Respiratory Therapeutics at Gilead Sciences and prior to that was Vice President Global Clinical Development, and Therapeutic Area (TA) Head for Hematology / Oncology, at Amgen Inc.

Dr Baynes graduated as a Medical Doctor and obtained a Master of Medicine and Doctor of Philosophy from the University of the Witwatersrand, Johannesburg, South Africa. He has had a long and distinguished career in the hematology-oncology-and stem cell transplantation fields, including drug development, basic research, clinical practice, clinical research, teaching and administration.

He is a member of many international societies, including the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and has authored some 150 publications. Before joining Industry in 2002, Dr Baynes was the Charles Martin Professor of Cancer Research at the Barbara Ann Karmanos Cancer Institute, an NCI designated Comprehensive Cancer Center, at Wayne State University, Detroit, Michigan, USA.

** ************
For speaker's contact information - Contact us



Interested Topics

Oncology, Research and Development, Clinical Research, Cancer Research, Hematology, Stem Cell Transplantation, Clinical Trials

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Send Message